Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. VHT: which is better?

Bottom line

XLV vs VHT: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and VHT (Vanguard Health Care Index Fund) have nearly the same top holdings — their top 25 positions are about 94% the same by weight.

But VHT is far broader, holding 407 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.

XLV is cheaper at 0.08% vs 0.09% — a difference of $1.00 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +7.2% for VHT (reporting dates differ).

Updated Nov 19, 2026

XLV vs VHT side by side

XLVVHT
TypeETFETF
Fund familySPDR (State Street)Vanguard
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.09%
Annual cost per $10k$8$9
10-yr cost on $10k (prospectus)$103$115
Max front loadNoneNone
12b-1 fee0.02%0%
1-yr return+14.5%+2.7%
5-yr return (annualized)+8.1%+7.2%
10-yr return (annualized)+9.8%+8.8%
Best quarter+14.5%+16.5%
Worst quarter−12.7%−13.1%
Net assets (fund)$40.6B$19.0B
Number of holdings65407
Portfolio turnover2%4%
Returns as ofDec 31, 2025Dec 31, 2024

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVVHTDifference
2024+2.5%+2.7%−0.1%
2023+2.0%+2.5%−0.5%
2022−2.1%−5.5%+3.5%
2021+25.9%+20.5%+5.4%
2020+13.3%+18.2%−4.9%
2019+20.7%+22.0%−1.3%
2018+6.3%+5.6%+0.7%
2017+21.7%+23.3%−1.6%
2016−2.8%−3.3%+0.5%

Source: Fund prospectus bar charts

Holdings overlap

23 of XLV's top 25 holdings also appear in VHT's top 25.

Shared top holdings
HoldingXLVVHT
Eli Lilly & Co16.51%14.04%
Johnson & Johnson10.64%8.47%
AbbVie Inc7.74%6.09%
UnitedHealth Group Inc6.57%5.45%
Merck & Co Inc5.52%4.66%
Amgen Inc3.40%2.87%
Thermo Fisher Scientific Inc3.24%2.93%
Abbott Laboratories2.75%2.35%
Gilead Sciences Inc2.73%2.64%
Intuitive Surgical Inc2.45%2.38%
Pfizer Inc2.39%2.35%
CVS Health Corp2.30%1.83%
Vertex Pharmaceuticals Inc2.19%1.80%
Danaher Corp2.09%1.84%
Bristol-Myers Squibb Co2.05%1.84%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

VHT top 10

  1. Eli Lilly & Co — 14.04%
  2. Johnson & Johnson — 8.47%
  3. AbbVie Inc — 6.09%
  4. UnitedHealth Group Inc — 5.45%
  5. Merck & Co Inc — 4.66%
  6. Thermo Fisher Scientific Inc — 2.93%
  7. Amgen Inc — 2.87%
  8. Gilead Sciences Inc — 2.64%
  9. Intuitive Surgical Inc — 2.38%
  10. Pfizer Inc — 2.35%

FAQ

What is the difference between XLV and VHT?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and VHT (Vanguard Health Care Index Fund) have nearly the same top holdings — their top 25 positions are about 94% the same by weight. But VHT is far broader, holding 407 positions to 65 for XLV, so beyond the top names it adds exposure XLV doesn't have.
Which is cheaper, XLV or VHT?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and VHT?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.